Transcranial Photobiomodulation With Patients With Parkinson's Disease
NCT ID: NCT06729125
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2024-12-15
2025-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Photobiomodulation and Parkinson
NCT03811613
Transcranial Photobiomodulation as a Therapy for Patients With Parkinson's Disease: Relationship Between Pain and Brain Functional Connectivity (FBM)
NCT05959772
Light Therapy in Parkinson's Disease
NCT02072642
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
NCT06297538
Effects of Transcranial Direct Current Stimulation on Postural Control
NCT03759132
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
transcranial photobiomodulation
Single-session transcranial laser stimulation was administered with a continuous-wave, 1,064-nm laser (Model CG-5000 Laser, Cell Gen Therapeutics LLC, Dallas, TX).
control group
exercises training
balance exercises and others
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial photobiomodulation
Single-session transcranial laser stimulation was administered with a continuous-wave, 1,064-nm laser (Model CG-5000 Laser, Cell Gen Therapeutics LLC, Dallas, TX).
exercises training
balance exercises and others
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hoehn \& Yahr stage I-IV,
* independent gait with or without technical assistance
* stable parkinsonian medication for at least a month before the study star.
Exclusion Criteria
* other neurological pathologies besides PD,
* chronic diseases not medically controlled and participation in another physiotherapy program or sport activity during the intervention period or in the month before starting the study
50 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Zaytoonah University of Jordan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanan Hosny M Battesha
associate professor hanan hosny M Battesha
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al Zaytoonah University
Amaan, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PD , LASER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.